KOHLBE THOMAS: Open Payments
NPI 1346707908 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 34 payments from 15 companies in 2025. Trend: 2023 $273 · 2024 $706 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $147 |
| Novo Nordisk Inc | 4 | $107 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Lilly USA, LLC | 3 | $62 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Exact Sciences Corporation | 1 | $32 |
| ABBVIE INC. | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| ViiV Healthcare Company | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
Products named: REXULTI, Wegovy, NEXIUM, MOUNJARO, JARDIANCE, Qelbree, Cologuard Collection Kit, SYNTHROID.
Industry payments across CO — which companies pay providers there.
